This Week in Addiction Medicine from ASAM

Jan 28 2025 100 ep. 7 mins 8
This Week in Addiction Medicine from ASAM Podcast artwork

A podcast source for news briefings on the top stories in the field of addiction medicine.

  Health & Fitness  News
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Lead: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning

Jan 28 2025 4 mins  
Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning JAMA Psychiatry This longitudinal cohort study examined the association of state-level medical and recreational cannabis laws with cannabis use disorder (CUD) and cannabis poisonings in the adult population with employer-sponsored health insurance. The study showed that from 2011 to 2021, s

Lead: Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice

Jan 21 2025 6 mins  
Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice American Journal of Psychiatry This narrative review discusses five clinically relevant and prevalent behavioral addictions that are common and often co-occur with psychiatric disorders such as depression and anxiety. Gambling disorder is the only behavioral addiction recognized as a clinical

ASAM Weekly Special Episode: Dr. David Fiellin & Dr. Eric Strain sit down to discuss the concept of Treatment Refractory Addiction

Jan 14 2025 26 mins  
Host Dr. Nick Athanasiou is joined by Dr. David Fiellin and Dr. Eric Strain to discuss the concept of Treatment Refractory Addiction. Why does the field of addiction medicine need this term, how is it defined and how the current treatment system aligns with the idea? Listen to the full interview to learn more! Treatment Failure Versus Failed Treatments: The Risks of Embracing Tre

Lead: Review of Evidence on Alcohol and Health

Jan 14 2025 6 mins  
Review of Evidence on Alcohol and Health National Academies of Sciences, Engineering, and Medicine To inform the next edition of the Dietary Guidelines for Americans (DGA), Congress tasked the National Academies with convening an expert committee to independently review the evidence on the relationship between moderate alcohol consumption and eight health outcomes including obesity

Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

Dec 17 2024 7 mins  
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies Psychological Medicine Using data from the EU-GEI case-control study and UK Biobank, researchers examined the independent and combined effect of heavy cannabis use and schizophrenia polygenic risk score (PRS), on risk for psychosis. Sch

Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students

Dec 10 2024 7 mins  
Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students Addiction This is an observational study using cross-sectional data from the American College Health Association–National College Health Assessment III. It measured the association between university-level prevalence of attention de

Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine

Dec 03 2024 5 mins  
Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine Clinical Chemistry This study of xylazine pharmacokinetics used plasma samples from 28 patients who had urine screens positive for xylazine and fentanyl. The patients were being treated for skin lesions, most commonly, then shortness of breath or opioid overdose. At least two subsequent plasma samples

Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study

Nov 19 2024 7 mins  
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study 🔓 Addiction This retrospective cohort study aimed to determine if opioid agonist therapy (OAT) in Scotland is protective against suicide, and measure trends in suicide rates in those with opioid dependence over time. The study included 46,453 indivi

Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity

Nov 05 2024 7 mins  
Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity 🔓 Alcohol Clinical and Experimental Research Using data from the Monitoring the Future study, which enrolled cohorts of high school seniors annually starting in 1976, this analysis evaluated alcohol drinking patterns in adults 35-60 and potential association with their drink

Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder

Oct 29 2024 5 mins  
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder JAMA Network This population-based retrospective cohort study assessed whether the use of buprenorphine/naloxone is associated with lower risk of treatment discontinuation and mortality compared with methadone. It included 30,891 individuals initiating treatment for the first time during the study period a